Microbot Medical (NASDAQ:MBOT – Get Free Report) posted its earnings results on Wednesday. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.02), Zacks reports.
Microbot Medical Price Performance
Shares of Microbot Medical stock opened at $1.53 on Friday. Microbot Medical has a 1-year low of $0.82 and a 1-year high of $3.38. The company has a market capitalization of $53.16 million, a PE ratio of -1.91 and a beta of 1.60. The business has a 50-day moving average of $1.74 and a 200-day moving average of $1.31.
Analyst Upgrades and Downgrades
Separately, HC Wainwright increased their price objective on shares of Microbot Medical from $7.00 to $9.00 and gave the company a “buy” rating in a research report on Friday, January 24th.
Microbot Medical Company Profile
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.
Featured Stories
- Five stocks we like better than Microbot Medical
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Archer Aviation Stock Sees Surge in Institutional Buys
- When to Sell a Stock for Profit or Loss
- These 4 Stocks Offer High Upside in the AI Data Center Boom
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- How Can Tomahawk 6 Contribute to Broadcom’s AI Growth Story?
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.
